Hong Kong-listed biotech firm Insilico Medicine Cayman TopCo is considering a secondary listing in Abu Dhabi, people familiar with the matter said, in a deal that would make it the first company from outside the Gulf to list shares on a regional exchange.
Hong Kong-listed biotech firm Insilico Medicine Cayman TopCo is considering a secondary listing in Abu Dhabi, people familiar with the matter said, in a deal that would make it the first company from outside the Gulf to list shares on a regional exchange.
<iframe src="https://statesidedaily.com/embed/cluster/a1685f2f085d424e920e6a9bf7a05c4b0e8a5889" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Hong Kong-Listed Biotech Insilico Is Said to Explore UAE Listing"></iframe>
